SCHEMBL13041518

SCHEMBL13041518

C[C@H](N)C(=O)Nc1cc(C(C)(C)c2ccccc2)n[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.42
XIAP P98170 8/20 0.40
BIRC2 Q13490 2/20 0.38
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
IDO1 P14902 2/20 0.36
LTA4H P09960 1/20 0.36
GAA P10253 1/20 0.36
CTRB1 P17538 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5487725 1.00 TAAR1 (0.42) TAAR1XIAPBIRC2MAPK13MAPK12
SCHEMBL5487119 0.84 SLC6A3 (0.33) TAAR1XIAPBIRC2
SCHEMBL8312713 0.82 MMP1 (0.35) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL5489292 0.82 MMP1 (0.35) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL2958400 0.82 MMP1 (0.35) MAPK13MAPK12MAPK11MAPK14GAA
SCHEMBL8317885 0.81 KEAP1 (0.37)
SCHEMBL8318141 0.81 ADORA1 (0.40) GAAADORA1SMN1; SMN2
SCHEMBL5491537 0.81 ADORA1 (0.40) GAAADORA1SMN1; SMN2
SCHEMBL2956506 0.81 KEAP1 (0.37)
SCHEMBL5491108 0.80 ADORA1 (0.38) CTRB1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100280066-A1 ACYLATED AMINO ACID AMIDYL PYRAZOLES AND RELATED COMPOUNDS TUNG JAY S 2010-11-04 US disclosed
US-7759382-B2 such as N-{5-[1-(4-chloro-phenyl)-1-methyl-ethyl]-2H-pyrazol-3-yl}-2-[2-(3,5-difluoro-phenyl)-2-hydroxy-acetylamino]-propionamide, used for inhibiting beta-amyloid peptide release and/or biosynthesis, inhibiting gamma-secretase activity, prevention and treatment of Alzheimer's disease ELAN PHARMACEUTICALS, INC. (US) 2010-07-20 US disclosed
US-20070197624-A1 Acylated amino acid amidyl pyrazoles and related compounds ELAN PHARMACEUTICALS, INC. (US) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280066-A1 ACYLATED AMINO ACID AMIDYL PYRAZOLES AND RELATED COMPOUNDS APP, BACE1, APH1A TAAR1 3427/4885XIAP 3372/4885BIRC2 2294/4885
US-20070197624-A1 Acylated amino acid amidyl pyrazoles and related compounds APP, BACE1, APH1A TAAR1 3427/4885XIAP 3372/4885BIRC2 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.